Huntington Acquiring Cadence Bank in $7.4 Billion Deal

BloombergMonday, October 27, 2025 at 2:36:38 PM
Huntington Acquiring Cadence Bank in $7.4 Billion Deal
Huntington Bancshares Inc. has announced its acquisition of Cadence Bank for $7.4 billion, marking its second significant purchase this year. This strategic move will expand Huntington's presence to 21 states across the southern and southeastern regions, enhancing its market reach and potential for growth. Such acquisitions are crucial as they allow banks to diversify their services and customer base, ultimately benefiting consumers and investors alike.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Huntington Reaches $7.4 Billion Deal to Buy Cadence Bank
PositiveFinancial Markets
Huntington has announced a significant $7.4 billion deal to acquire Cadence Bank, marking a notable moment in the banking sector as consolidation trends resurface. This acquisition is crucial as banks are under increasing pressure to enhance their competitiveness in a rapidly changing financial landscape. Such mergers can lead to improved services and greater stability for customers, making this deal a key development in the industry.
Huntington Reaches $7.4 Billion Deal to Buy Cadence Bank
PositiveFinancial Markets
Huntington has announced a significant $7.4 billion deal to acquire Cadence Bank, marking a notable moment in the banking sector as consolidation trends resurface. This acquisition is important as it reflects the ongoing pressure banks face to enhance their competitiveness in a rapidly changing financial landscape, potentially leading to improved services and offerings for customers.
Latest from Financial Markets
Home Office squandered billions on asylum hotels, MPs say
NegativeFinancial Markets
A recent report by MPs reveals that the Home Office has wasted billions on asylum hotels due to flawed contracts and incompetent delivery. This mismanagement has left the department struggling to meet the growing demand for asylum accommodation, raising concerns about the effectiveness of government spending and the treatment of asylum seekers in the UK.
Argentine bonds and currency surge after victory for Javier Milei’s party
PositiveFinancial Markets
Argentina's financial markets are experiencing a significant boost following the electoral victory of Javier Milei's party. Investors are optimistic that this endorsement will ensure the continuation of the president's market-friendly reforms, which are crucial for the country's economic stability and growth. This surge in bonds and currency reflects a renewed confidence in Argentina's economic direction, making it a pivotal moment for both local and international investors.
Caroline Flack’s Mother Reveals Heartbreaking Regret in Disney+ Documentary
NegativeFinancial Markets
In a poignant new Disney+ documentary, Caroline Flack's mother opens up about her deep regrets following her daughter's tragic death. This heartfelt revelation sheds light on the struggles faced by those dealing with mental health issues and the importance of support systems. It matters because it encourages conversations around mental health and the impact of loss, reminding us to cherish our loved ones and seek help when needed.
Keurig Dr Pepper Soars; Carter's Falls; Avidity Biosciences Rallies
PositiveFinancial Markets
Keurig Dr Pepper's shares have surged ahead of the New York market opening after the company raised its fiscal 2025 sales growth forecast to a high-single-digit range, a significant upgrade from its previous outlook. This positive shift comes alongside a $7 billion financing deal with Apollo and KKR to support its acquisition of JDE Peet’s NV, addressing investor concerns about debt levels. Meanwhile, Carter's shares have declined, and Avidity Biosciences has seen a rally, highlighting the dynamic nature of the stock market.
Shaw Thomas, president and CEO of Retractable, buys $338 in RVP
PositiveFinancial Markets
Shaw Thomas, the president and CEO of Retractable, has made a notable investment by purchasing $338 in RVP. This move highlights his confidence in the company's future and could signal positive growth ahead. Such investments from leadership often inspire trust among stakeholders and can lead to increased interest in the company's performance.
Revolution Medicines stock rises after FDA grants Orphan Drug Designation
PositiveFinancial Markets
Revolution Medicines saw a significant boost in its stock price following the FDA's decision to grant Orphan Drug Designation for its promising treatment. This designation is crucial as it provides incentives for the development of drugs aimed at rare diseases, potentially leading to faster market access and increased funding opportunities. Investors are optimistic about the company's future prospects, as this recognition could pave the way for successful clinical trials and ultimately benefit patients in need.